side effects of covid vaccine first dose

SIDE EFFECTS OF COVID VACCINE FIRST DOSE FULL
SIDE EFFECTS OF COVID VACCINE FIRST DOSE LICENSE

This will be prioritized according to the populations identified by the CDC’s Advisory Committee on Immunization Practices (ACIP) guidelines. government will manage allocation and distribution of the vaccine in the U.S. The Company plans to deliver 100 million single-shot vaccines to the U.S.

SIDE EFFECTS OF COVID VACCINE FIRST DOSE FULL

The Company has begun shipping its COVID-19 vaccine and expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20 million people in the U.S. Johnson & Johnson is committed to making its COVID-19 vaccine available on a not-for-profit basis for emergency pandemic use. “We look forward to our continued efforts around the world as we collectively aim to change the trajectory of this global pandemic.” A vaccine that protects against COVID-19, especially against the most dire outcomes of hospitalization and death, will help ease the burden on people and the strain on health systems worldwide,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “We believe the Johnson & Johnson single-shot COVID-19 vaccine is a critical tool for fighting this global pandemic, particularly as it shows protection across countries with different variants.

“We will do everything we can to help bring this pandemic to an end, in the United States and throughout the world.” “This milestone follows a year of incredible work by our dedicated teams and unprecedented collaboration with health leaders around the world – all of whom shared a goal of bringing a single-shot vaccine to the public,” said Alex Gorsky, Chairman and Chief Executive Officer at Johnson & Johnson.

SIDE EFFECTS OF COVID VACCINE FIRST DOSE LICENSE

The Company plans to file for a Biologics License Application (BLA) with the FDA later in 2021. The terms of the EUA allow use of the vaccine while more data are gathered.

This decision was based on the totality of scientific evidence, including data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease across all regions studied, and showed protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.

NEW BRUNSWICK, N.J., Febru– Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S.

Side effects of covid vaccine first dose